相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas
Hanna Lee et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
被撤回的出版物: Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer (Retracted article. See vol. 19, pg. 508, 2013)
Eddy S. Leman et al.
CLINICAL CANCER RESEARCH (2008)
Novel blood-based, five-gene biomarker set for the detection of colorectal cancer
Mark Han et al.
CLINICAL CANCER RESEARCH (2008)
DNA methylation biomarkers for blood-based colorectal cancer screening
Catherine Lofton-Day et al.
CLINICAL CHEMISTRY (2008)
Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes
Chih-Ching Wu et al.
PROTEOMICS (2008)
Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer
Jong Wook Chang et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer
Nanna Moller Sorensen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
From the genome to the proteome-biomarkers in colorectal cancer
Jens K. Habermann et al.
LANGENBECKS ARCHIVES OF SURGERY (2008)
Elevated serum matrix metalloproteinase 9 (MMP-9) concentration predicts the presence of colorectal neoplasia in symptomatic patients
N. G. Hurst et al.
BRITISH JOURNAL OF CANCER (2007)
Blood markers for early detection of colorectal cancer: A systematic review
Sabrina Hundt et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Innovative proteomic approaches for cancer biomarker discovery
Vitor Faca et al.
BIOTECHNIQUES (2007)
Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients
Joan Maurel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Cancer genomics: integrating form and function
So Young Kim et al.
CARCINOGENESIS (2007)
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2007)
Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis
Barbara Mroczko et al.
CLINICA CHIMICA ACTA (2007)
Minimally invasive biomarkers for detection and staging of colorectal cancer
Ronald A. Booth
CANCER LETTERS (2007)
Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis
Markus Roessler et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors
Jens K. Habermann et al.
GASTROENTEROLOGY (2006)
Identification of serum biomarkers for colon cancer by proteomic analysis
D. G. Ward et al.
BRITISH JOURNAL OF CANCER (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry
Judith Y. M. N. Engwegen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool
CC Liew et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients
Barbara Mroczko et al.
CLINICA CHIMICA ACTA (2006)
Increasing incidence of colorectal cancer in Asia: implications for screening
JJY Sung et al.
LANCET ONCOLOGY (2005)
Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer
M Roessler et al.
CLINICAL CANCER RESEARCH (2005)
Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer
MW Volmer et al.
PROTEOMICS (2005)
Discovery and identification of α-defensins as low abundant, tumor-derived serum markers in colorectal cancer
C Melle et al.
GASTROENTEROLOGY (2005)
Serum laminin is an independent prognostic factor in colorectal cancer
N Saito et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2005)
Colorectal cancer screening in average risk individuals
CS Huang et al.
CANCER CAUSES & CONTROL (2005)
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study
J Albrethsen et al.
BMC CANCER (2005)
Diet and cancer - The European prospective investigation into cancer and nutrition
S Bingham et al.
NATURE REVIEWS CANCER (2004)
Plasma TIMP-1 in patients with colorectal adenomas:: a prospective study
MN Holten-Andersen et al.
EUROPEAN JOURNAL OF CANCER (2004)
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population
TF Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Plasma prolactin in patients with colorectal cancer
AR Soroush et al.
BMC CANCER (2004)
Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study
M Holten-Andersen et al.
EUROPEAN JOURNAL OF CANCER (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
DNA integrity as a potential marker for stool-based detection of colorectal cancer
KA Boynton et al.
CLINICAL CHEMISTRY (2003)
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
MJ Duffy et al.
EUROPEAN JOURNAL OF CANCER (2003)
Colorectal cancer screening and surveillance: Clinical guidelines and rationale - Update based on new evidence
S Winawer et al.
GASTROENTEROLOGY (2003)
Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel
DA Ahlquist et al.
GASTROENTEROLOGY (2000)
分享论文
